The auto injector market represents a rapidly expanding segment within the global pharmaceutical delivery systems industry, driven by the increasing prevalence of chronic diseases and the growing ...

The auto-injectors market is forecast to reach a value of USD 5.71 billion in 2025 and is expected to expand to USD 23.31 billion by 2035, growing at a steady compound annualgrowth rate of 8.2% over ...

MHRA has issued a drug alert for the Emerade adrenaline auto-injector device, as a result of the device’s potential to fail in delivery of the dose due to blockage of the needle. The Medicines and ...

Moving to a new type of auto-injector device gave Fiona Garnett the chance to address an area of anaphylaxis provision which had worried her. “I get concerned because parents and carers request a ...

Bespak has announced the launch of the Syrina™ AR 2.25 auto-injector. This innovative auto-injector is the latest addition to the VapourSoft™ -powered Syrina range and is suitable for delivering ...

GPs should restrict adrenaline auto-injector prescriptions due to ongoing supply issues, the Department of Health and Social Care has said. The Government alert told GPs that ‘interruptions in the ...

There's no doubt that self-injection devices have transformed the lives of people with chronic diseases like diabetes, making it easier to receive treatment, whilst also reducing risks like New Jersey ...

The new Syrina 2.25 is a compact auto-injector that uses the standard 2.25 mL prefilled syringe, based on Bespak’s proprietary VapourSoft technology. Drug-delivery company, Bespak, is launching its ...

With just over a month away, SMi's Pre-Filled Syringes West Coast show (June 4 - 5, San Diego, CA) is set to beat the record in attendee interest. Set to attend the event are: AbbVie, Allergan, Amgen, ...

In 2003 Merck Serono, a world leader in the field of biotechnology engaged PDD to design an auto-injector for its Growth Hormone (GH) therapy product Saizen®. In what was a saturated and static market ...

The number of auto-injector devices prescribed for individuals varies significantly, not just from local area to local area but also from GP practice to GP practice and sometimes even from GP to GP.